Alto Neuroscience Inc

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$20.58

+0.39 (+1.93%)

As of Mar 25, 2:55 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 88%

Hold 2 13%

Sell 0 0%

Price Target

Analyst Price Target +7.7% upside

Low Target $14.63

Average Target $22.17

High Target $27.87

Current Price $20.58

Current
$20.58

Target
$22.17

$14.63 $22.17 avg $27.87

Scenario Analysis

Bear Case

$14.63

-28.9%

Low target

Base Case

$22.17

+7.7%

Avg target

Bull Case

$27.87

+35.4%

High target

Risk/Reward

1.2x

Balanced

Price in Context

52-Week High

$20.91

-1.6% from high

52-Week Low

$1.60

+1,186.3% from low

Target vs 52W High

$22.17

+6.0% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+45.2%
JNJ Johnson & Johnson	Buy	32	59%	$299.55	+24.8%
MRK Merck & Co. Inc.	Buy	36	67%	$159.27	+33.4%
PFE Pfizer Inc.	Hold	35	40%	$33.90	+24.3%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+196.1%
ZTS Zoetis Inc	Buy	25	64%	$209.87	+79.8%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-22.9%
VTRS Viatris Inc	Buy	18	67%	$122.82	+809.8%